ARTICLE | Clinical News
GLV-1h68: Phase Ib started
August 15, 2016 7:00 AM UTC
Genelux began an open-label, dose-escalation, U.S. Phase Ib trial to evaluate GL-ONC1 given via intraperitoneal infusion in about 12 patients. ...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Genelux began an open-label, dose-escalation, U.S. Phase Ib trial to evaluate GL-ONC1 given via intraperitoneal infusion in about 12 patients. ...